192 related articles for article (PubMed ID: 33633232)
1. Molecular imaging of orthotopic prostate cancer with nanobubble ultrasound contrast agents targeted to PSMA.
Wang Y; De Leon AC; Perera R; Abenojar E; Gopalakrishnan R; Basilion JP; Wang X; Exner AA
Sci Rep; 2021 Feb; 11(1):4726. PubMed ID: 33633232
[TBL] [Abstract][Full Text] [Related]
2. Optimized Anti-Prostate-Specific Membrane Antigen Single-Chain Variable Fragment-Loaded Nanobubbles as a Novel Targeted Ultrasound Contrast Agent for the Diagnosis of Prostate Cancer.
Ding Y; Cao Q; Qian S; Chen X; Xu Y; Chen J; Shen H
J Ultrasound Med; 2020 Apr; 39(4):761-773. PubMed ID: 31702068
[TBL] [Abstract][Full Text] [Related]
3. Prostate-specific membrane antigen targeted protein contrast agents for molecular imaging of prostate cancer by MRI.
Pu F; Salarian M; Xue S; Qiao J; Feng J; Tan S; Patel A; Li X; Mamouni K; Hekmatyar K; Zou J; Wu D; Yang JJ
Nanoscale; 2016 Jul; 8(25):12668-82. PubMed ID: 26961235
[TBL] [Abstract][Full Text] [Related]
4. PSMA-targeted contrast agents for intraoperative imaging of prostate cancer.
Bao K; Lee JH; Kang H; Park GK; El Fakhri G; Choi HS
Chem Commun (Camb); 2017 Feb; 53(10):1611-1614. PubMed ID: 28085163
[TBL] [Abstract][Full Text] [Related]
5. Diagnosis of prostate cancer using anti-PSMA aptamer A10-3.2-oriented lipid nanobubbles.
Fan X; Guo Y; Wang L; Xiong X; Zhu L; Fang K
Int J Nanomedicine; 2016; 11():3939-50. PubMed ID: 27574424
[TBL] [Abstract][Full Text] [Related]
6. Real time ultrasound molecular imaging of prostate cancer with PSMA-targeted nanobubbles.
Perera RH; de Leon A; Wang X; Wang Y; Ramamurthy G; Peiris P; Abenojar E; Basilion JP; Exner AA
Nanomedicine; 2020 Aug; 28():102213. PubMed ID: 32348874
[TBL] [Abstract][Full Text] [Related]
7. Construction and in vitro/in vivo targeting of PSMA-targeted nanoscale microbubbles in prostate cancer.
Wang L; Li L; Guo Y; Tong H; Fan X; Ding J; Huang H
Prostate; 2013 Aug; 73(11):1147-58. PubMed ID: 23532872
[TBL] [Abstract][Full Text] [Related]
8. Quantification of extravasation and binding of PSMA-targeted nanobubbles by modelling the second-wave phenomenon.
Chen C; Perera R; Mischi M; Kolios M; Exner A; Turco S
Mol Imaging Biol; 2024 Apr; 26(2):253-263. PubMed ID: 38151581
[TBL] [Abstract][Full Text] [Related]
9. Development of polymeric microbubbles targeted to prostate-specific membrane antigen as prototype of novel ultrasound contrast agents.
Sanna V; Pintus G; Bandiera P; Anedda R; Punzoni S; Sanna B; Migaleddu V; Uzzau S; Sechi M
Mol Pharm; 2011 Jun; 8(3):748-57. PubMed ID: 21545176
[TBL] [Abstract][Full Text] [Related]
10. Paclitaxel-loaded and A10-3.2 aptamer-targeted poly(lactide-
Wu M; Wang Y; Wang Y; Zhang M; Luo Y; Tang J; Wang Z; Wang D; Hao L; Wang Z
Int J Nanomedicine; 2017; 12():5313-5330. PubMed ID: 28794625
[TBL] [Abstract][Full Text] [Related]
11. Development and characterization of a theranostic multimodal anti-PSMA targeting agent for imaging, surgical guidance, and targeted photodynamic therapy of PSMA-expressing tumors.
Lütje S; Heskamp S; Franssen GM; Frielink C; Kip A; Hekman M; Fracasso G; Colombatti M; Herrmann K; Boerman OC; Gotthardt M; Rijpkema M
Theranostics; 2019; 9(10):2924-2938. PubMed ID: 31244933
[No Abstract] [Full Text] [Related]
12. Pharmacokinetic modeling of PSMA-targeted nanobubbles for quantification of extravasation and binding in mice models of prostate cancer.
Chen C; Perera R; Kolios MC; Wijkstra H; Mischi M; Exner AA; Turco S
Med Phys; 2022 Oct; 49(10):6547-6559. PubMed ID: 36049109
[TBL] [Abstract][Full Text] [Related]
13. Six-Transmembrane Epithelial Antigen of the Prostate-1 (STEAP-1)-Targeted Ultrasound Imaging Microbubble Improves Detection of Prostate Cancer In Vivo.
Yuan Y; Liu Y; Zhu XM; Hu J; Zhao CY; Jiang F
J Ultrasound Med; 2019 Feb; 38(2):299-305. PubMed ID: 30027616
[TBL] [Abstract][Full Text] [Related]
14.
Werner RA; Derlin T; Lapa C; Sheikbahaei S; Higuchi T; Giesel FL; Behr S; Drzezga A; Kimura H; Buck AK; Bengel FM; Pomper MG; Gorin MA; Rowe SP
Theranostics; 2020; 10(1):1-16. PubMed ID: 31903102
[TBL] [Abstract][Full Text] [Related]
15. Targeted Nanobubbles Carrying Indocyanine Green for Ultrasound, Photoacoustic and Fluorescence Imaging of Prostate Cancer.
Wang Y; Lan M; Shen D; Fang K; Zhu L; Liu Y; Hao L; Li P
Int J Nanomedicine; 2020; 15():4289-4309. PubMed ID: 32606678
[TBL] [Abstract][Full Text] [Related]
16. Development of prostate specific membrane antigen targeted ultrasound microbubbles using bioorthogonal chemistry.
Zlitni A; Yin M; Janzen N; Chatterjee S; Lisok A; Gabrielson KL; Nimmagadda S; Pomper MG; Foster FS; Valliant JF
PLoS One; 2017; 12(5):e0176958. PubMed ID: 28472168
[TBL] [Abstract][Full Text] [Related]
17. PGC and PSMA in prostate cancer diagnosis: tissue analysis from biopsy samples.
Antunes AA; Reis ST; Leite KR; Real DM; Sousa-Canavez JM; Camara-Lopes LH; Dall'Oglio MF; Srougi M
Int Braz J Urol; 2013; 39(5):649-56. PubMed ID: 24267108
[TBL] [Abstract][Full Text] [Related]
18. Photosensitizer-based multimodal PSMA-targeting ligands for intraoperative detection of prostate cancer.
Derks YHW; Rijpkema M; Amatdjais-Groenen HIV; Kip A; Franssen GM; Sedelaar JPM; Somford DM; Simons M; Laverman P; Gotthardt M; Löwik DWPM; Lütje S; Heskamp S
Theranostics; 2021; 11(4):1527-1541. PubMed ID: 33408764
[TBL] [Abstract][Full Text] [Related]
19. Prostate Cancer Targeted X-Ray Fluorescence Imaging via Gold Nanoparticles Functionalized With Prostate-Specific Membrane Antigen (PSMA).
Hara D; Tao W; Totiger TM; Pourmand A; Dogan N; Ford JC; Shi J; Pollack A
Int J Radiat Oncol Biol Phys; 2021 Sep; 111(1):220-232. PubMed ID: 33964351
[TBL] [Abstract][Full Text] [Related]
20. Comparison of
Zamboglou C; Drendel V; Jilg CA; Rischke HC; Beck TI; Schultze-Seemann W; Krauss T; Mix M; Schiller F; Wetterauer U; Werner M; Langer M; Bock M; Meyer PT; Grosu AL
Theranostics; 2017; 7(1):228-237. PubMed ID: 28042330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]